Robert S. Miller, MD. Elaine Towle and Tom Barr discuss the latest National Practice Benchmark Report from Oncology Metrics and review the trends and business climate affecting oncology practices this year ..read more

by Robert S. Miller, MD. Tom Barr and Elaine Towle of Oncology Metrics discuss the state of oncology practice based on data from the annual National Practice Benchmark report, noting the marked resilience and adaptability of the oncology delivery system and the surprising degree of stability of the business structures for many of today’s physician-owned practices ..read more

Dr. Nathan Pennell, Dr. Muhammed Beg and Ms. Erin Williams discuss improving the time-to-activation of new clinical trials at an NCI-Designated Comprehensive Cancer Center. Read the article: https://ascopubs.org/doi/full/10.1200/OP.19.00325   TRANSCRIPT [PIANO MUSIC PLAYING] DR. PENNELL: Welcome to the latest Journal of Oncology Practice podcast brought to you by the ASCO Podcast Network, a collection of nine programs covering a range of educational and scientific content and offering enriching insight into the world of cancer care. You can find all recordings, including this one, at podc ..read more

Dr. Nate Pennell talks with Dr. Joel Segel about “Coverage, Financial Burden, and the Affordable Care Act for Cancer Patients.” Article available online at Journal of Oncology Practice. TRANSCRIPT Support for Journal of Oncology Practice podcasts is provided in part by AstraZeneca, dedicated to advancing options and providing hope for people living with cancer. More information at astrazeneca.us.com. [MUSIC PLAYING] Welcome to the latest Journal of Oncology Practice podcast, brought to you by the ASCO Podcast Network, a collection of nine programs covering a range of educational and scien ..read more

Dr. Nate Pennell discusses "How to Know if a Somatic Tumor Mutation is Targetable" with Suanna Bruinooge, the director of research, strategy, and operations at ASCO's Center for Research and Analytics, or CENTRA, and Dr. Richard Schilsky, senior vice president and chief medical officer at ASCO. Read the related article "Determining If a Somatic Tumor Mutation Is Targetable and Options for Accessing Targeted Therapies."   [DR. NATHAN PENNELL] Welcome to the latest Journal of Oncology Practice Podcast brought to you by the ASCO Podcast Network, a collection of nine programs covering a range ..read more

Dr. Pennell and Dr. Kircher discuss the push for increased price transparency among stakeholders in an effort to control the rising costs of healthcare. Read the related article on ascopubs.org.   TRANSCRIPT: Welcome to the latest Journal of Oncology Practice podcast, brought to you by the ASCO Podcast Network, a collection of nine programs covering a range of educational and scientific content and offering enriching insight into the world of cancer care. You can find all recordings, including this one, at podcast.asco.org. My name is Dr. Nate Pennell, medical oncologist at the Cleveland ..read more

by Robert S. Miller, MD. Tom Barr and Elaine Towle of Oncology Metrics discuss the state of oncology practice based on data from the annual National Practice Benchmark report, noting the marked resilience and adaptability of the oncology delivery system and the surprising degree of stability of the business structures for many of today’s physician-owned practices ..read more

by Robert S. Miller, MD. Dr. Reshma Jagsi and collaborators conducted interviews with medical oncologists to ascertain their attitudes toward and prior experiences with the systematic collection of patient-reported outcomes (PROs) in community oncology and to identify barriers to wider implementation ..read more

by Robert S. Miller, MD. Dr. Douglas Blayney reviews some of the research and presentations from the first ASCO Quality Care Symposium held in San Diego (Nov. 30 - Dec. 1, 2013), and covered in the special May 2013 issue of the JOP ..read more

By Robert S. Miller, MD. Michael Neuss and Martha Polovich discuss the recent updates to the ASCO/ONS chemotherapy administration standards, focusing on the safe administration and management of oral chemotherapy ..read more